{"id":"W4402565731","doi":"10.1016/j.annonc.2024.08.2284","title":"LBA43 10-y survival outcomes from the phase III CheckMate 067 trial of nivolumab plus ipilimumab in advanced melanoma","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Oncology; Internal medicine; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002044482,0.0006680924,0.001118943,0.0002244279,0.0003300076,0.001059136,0.0005304446,0.0007540675,0.002921778],"category_scores_gemma":[0.001519958,0.0002192018,0.002811256,0.0003100983,0.0003183991,0.0007465158,0.0005554244,0.00250303,0.0005946077],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008051333,"about_ca_system_score_gemma":0.0008380704,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002425514,"about_ca_topic_score_gemma":0.006601735,"domain_scores_codex":[0.999423,0.0002644975,0.0000245723,0.00009516608,0.00006612557,0.0001267108],"domain_scores_gemma":[0.9991646,0.000196199,0.0002001412,0.00008409684,0.0000667704,0.0002882619],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6950999,0.004673068,0.07055907,0.001763757,0.01508358,0.0002636767,0.0002626117,0.009791062,0.009366008,0.0009897896,0.03802123,0.1541261],"study_design_scores_gemma":[0.2332163,0.1608286,0.5240129,0.0007437656,0.02835633,0.0007918465,0.0004242288,0.009524004,0.004597617,0.002912454,0.03438916,0.0002027237],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9783806,0.01000789,0.00029291,0.001324431,0.0003097342,0.000152507,0.005171825,0.00006184389,0.00429822],"genre_scores_gemma":[0.9829279,0.002631441,0.000284361,0.001493722,0.0002966161,0.0002140182,0.008640954,0.00003592156,0.003475311],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002921778,"threshold_uncertainty_score":0.0108124,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09439874432614945,"score_gpt":0.4237533734174347,"score_spread":0.3293546290912852,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}